COVID-19 Clinical News | Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Covid-19

Omicron covid variant remains infective for 21 hours on human skin

Omicron Covid variant remains infective for 21 hours on human skin

ICU patients still display physical, mental and cognitive problems one year after COVID-19

ICU patients still display physical, mental and cognitive problems one year after COVID-19

Neurological manifestations seen in nearly half of children with COVID-19 and MIS-C

Neurological manifestations seen in nearly half of children with COVID-19 and MIS-C

Booster COVID-19 vaccination improves immune response in cancer patients undergoing treatment

Booster COVID-19 vaccination improves immune response in cancer patients undergoing treatment

Casirivimab and imdevimab combination reduces incidence of symptomatic COVID-19

Casirivimab and imdevimab combination reduces incidence of symptomatic COVID-19

Vaccination leads to smaller reduction in transmission of delta compared to alpha COVID-19 variants

patient with cold

Cross-reactive T cells offer protection against COVID-19 infection

Point-of-care COVID-19 test in ED significantly reduces turnaround-time

Point-of-care COVID-19 test in ED significantly reduces turnaround-time

Self-reported long COVID affecting 2% of the UK population

Self-reported long COVID affecting 2% of the UK population

omicron variant

Study shows third COVID-19 vaccine dose 37% effective against Omicron after 7 days

omicron variant

Omicron infection causes fewer hospitalisations and severe disease compared with Delta variant

Oxford vaccine

Oxford vaccine protection against severe COVID-19 wanes three months after second dose